In a regulatory filing, Nuvation Bio disclosed that its director Kim Blickenstaff bought 172K shares of common stock on June 11th in a total transaction size of $500K. Shares of Nuvation Bio are up 4.7% afterhours at $3.13.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NUVB: